Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012317) titled 'A Clinical Trial to Compare the Degree of Gastric Acid Suppression Following Administration of Rabeprazole or Zastaprazan in Healthy Volunteers' on July 22.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(To evaluate gastric pH suppression profile after 7-day repeated doses of rabeprazole or zastaprazan), Intervention Model : Cross-over, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Seoul National University Hospital
Condition:
Diseases of the digestive system
Intervention:
Drug : Part1 sequence1: rabeprazole 20 mg PO QD x 7 days -> wash-out 10 days -> zastaprazan 20 mg PO QD ...